409 related articles for article (PubMed ID: 17095199)
1. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
[TBL] [Abstract][Full Text] [Related]
2. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
Talvik M; Nordström AL; Olsson H; Halldin C; Farde L
Int J Neuropsychopharmacol; 2003 Dec; 6(4):361-70. PubMed ID: 14604451
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET study.
Nakajima S; Caravaggio F; Mamo DC; Mulsant BH; Chung JK; Plitman E; Iwata Y; Gerretsen P; Uchida H; Suzuki T; Mar W; Wilson AA; Houle S; Graff-Guerrero A
Schizophr Res; 2015 May; 164(1-3):263-7. PubMed ID: 25757713
[TBL] [Abstract][Full Text] [Related]
5. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
[TBL] [Abstract][Full Text] [Related]
6. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
[TBL] [Abstract][Full Text] [Related]
7. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
Karlsson P; Farde L; Halldin C; Sedvall G
Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
[TBL] [Abstract][Full Text] [Related]
8. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
9. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
Hirvonen J; Aalto S; Lumme V; Någren K; Kajander J; Vilkman H; Hagelberg N; Oikonen V; Hietala J
Nucl Med Commun; 2003 Dec; 24(12):1207-14. PubMed ID: 14627846
[TBL] [Abstract][Full Text] [Related]
10. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.
Graff-Guerrero A; Mamo D; Shammi CM; Mizrahi R; Marcon H; Barsoum P; Rusjan P; Houle S; Wilson AA; Kapur S
Arch Gen Psychiatry; 2009 Jun; 66(6):606-15. PubMed ID: 19487625
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
Olsson H; Halldin C; Farde L
Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
[TBL] [Abstract][Full Text] [Related]
12. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
[TBL] [Abstract][Full Text] [Related]
13. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L
Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
Hsiao MC; Lin KJ; Liu CY; Tzen KY; Yen TC
Schizophr Res; 2003 Dec; 65(1):39-46. PubMed ID: 14623373
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
16. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
Alakurtti K; Aalto S; Johansson JJ; Någren K; Tuokkola T; Oikonen V; Laine M; Rinne JO
J Cereb Blood Flow Metab; 2011 Jan; 31(1):155-65. PubMed ID: 20442726
[TBL] [Abstract][Full Text] [Related]
18. Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression--A [¹¹C] raclopride PET-study.
Ledermann K; Jenewein J; Sprott H; Hasler G; Schnyder U; Warnock G; Johayem A; Kollias S; Buck A; Martin-Soelch C
Eur Neuropsychopharmacol; 2016 Feb; 26(2):320-330. PubMed ID: 26708319
[TBL] [Abstract][Full Text] [Related]
19. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
Olsson H; Farde L
Neuroimage; 2001 Oct; 14(4):936-45. PubMed ID: 11554812
[TBL] [Abstract][Full Text] [Related]
20. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
Farde L; Suhara T; Nyberg S; Karlsson P; Nakashima Y; Hietala J; Halldin C
Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]